DD11922A - - Google Patents

Info

Publication number
DD11922A
DD11922A DD11922DA DD11922A DD 11922 A DD11922 A DD 11922A DD 11922D A DD11922D A DD 11922DA DD 11922 A DD11922 A DD 11922A
Authority
DD
German Democratic Republic
Application number
Publication of DD11922A publication Critical patent/DD11922A/xx

Links

DD11922D DD11922A (en)

Publications (1)

Publication Number Publication Date
DD11922A true DD11922A (en)

Family

ID=224027

Family Applications (1)

Application Number Title Priority Date Filing Date
DD11922D DD11922A (en)

Country Status (1)

Country Link
DD (1) DD11922A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2246778A (en) * 1990-08-08 1992-02-12 Norgine Ltd Propylamine derivatives

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2246778A (en) * 1990-08-08 1992-02-12 Norgine Ltd Propylamine derivatives
GB2246778B (en) * 1990-08-08 1993-09-29 Norgine Ltd Improvements in or relating to propylamine derivatives

Similar Documents

Publication Publication Date Title
AU641799B2 (en) Propylamine derivatives
EP4134363A1 (en) Pharmaceutical composition for preventing or treating muscular weakness-related diseases comprising alverine, 4-hydroxy alverine, derivative thereof, or pharmaceutically acceptable salt thereof
US20060223891A1 (en) Use of alverine, alone or in combination with a tricyclic antidepressant or an antidepressant which is a specific inhibitor of serotonin reuptake for treatment of depression
FR2900337A1 (en) USE OF ALVERINE FOR THE TREATMENT OF SEXUAL DYSFUNCTIONS
FR2855970A1 (en) Treatment of depression without significant side-effects, comprises administration of alverine or its metabolites, showing strong affinity for sigma-1, sigma-2 and 5-HT1a receptors
DD11922A (en)